(VSCO) Victoria's Secret - Overview
Sector: Consumer CyclicalIndustry: Apparel Retail | Exchange NYSE (USA) | Currency USD | Market Cap: 3.586m | Total Return 126.8% in 12m
Stock: Bras, Lingerie, Panties, Sleepwear, Fragrance
Total Rating 61
Risk 72
Buy Signal 0.01
| Risk 5d forecast | |
|---|---|
| Volatility | 63.6% |
| Relative Tail Risk | -5.94% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.47 |
| Alpha | 87.26 |
| Character TTM | |
|---|---|
| Beta | 2.626 |
| Beta Downside | 2.272 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.47% |
| CAGR/Max DD | 0.15 |
EPS (Earnings per Share)
Revenue
Description: VSCO Victoria's Secret March 03, 2026
Victoria’s Secret & Co. (NYSE: VSCO) is a specialty retailer that sells women’s intimate apparel, sleepwear, loungewear, activewear, swimwear, and beauty products under the Victoria’s Secret, PINK and Adore Me brands. Its distribution mix includes company-owned stores, franchise and licensing partners, and a growing suite of e-commerce sites such as VictoriasSecret.com, PINK.com, AdoreMe.com and DailyLook.com.
Key recent metrics show the business is rebounding: FY 2024 same-store sales rose 6.2% YoY, while digital sales grew 14% as the company expands its omnichannel footprint. Gross margin improved to 38.5% after cost-saving initiatives, and the firm reported a 2024 Q2 adjusted EBITDA of $112 million, reflecting stronger brand positioning amid a consumer-discretionary environment supported by stabilising inflation and modest wage growth.
For deeper valuation insights, you might explore ValueRay’s analysis of VSCO.
Headlines to watch out for
- Intimate apparel sales drive core revenue growth
- Digital channel expansion boosts online sales penetration
- Supply chain costs impact merchandise profitability
- Consumer discretionary spending influences product demand
- Brand perception shifts affect market share
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 160.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.77 > 1.0 |
| NWC/Revenue: 5.74% < 20% (prev 1.06%; Δ 4.68% < -1%) |
| CFO/TA 0.10 > 3% & CFO 499.0m > Net Income 160.9m |
| Net Debt (2.33b) to EBITDA (460.1m): 5.06 < 3 |
| Current Ratio: 1.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (85.8m) vs 12m ago 3.25% < -2% |
| Gross Margin: 36.38% > 18% (prev 0.37%; Δ 3.60k% > 0.5%) |
| Asset Turnover: 137.3% > 50% (prev 137.4%; Δ -0.12% > 0%) |
| Interest Coverage Ratio: 0.66 > 6 (EBITDA TTM 460.1m / Interest Expense TTM 69.7m) |
Altman Z'' 1.02
| A: 0.08 (Total Current Assets 1.88b - Total Current Liabilities 1.51b) / Total Assets 5.01b |
| B: 0.10 (Retained Earnings 504.0m / Total Assets 5.01b) |
| C: 0.01 (EBIT TTM 46.1m / Avg Total Assets 4.77b) |
| D: 0.12 (Book Value of Equity 511.0m / Total Liabilities 4.10b) |
| Altman-Z'' Score: 1.02 = BB |
Beneish M -3.06
| DSRI: 1.11 (Receivables 186.0m/159.0m, Revenue 6.55b/6.23b) |
| GMI: 1.01 (GM 36.38% / 36.65%) |
| AQI: 0.83 (AQ_t 0.15 / AQ_t-1 0.18) |
| SGI: 1.05 (Revenue 6.55b / 6.23b) |
| TATA: -0.07 (NI 160.9m - CFO 499.0m) / TA 5.01b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of VSCO shares?
As of March 27, 2026, the stock is trading at USD 44.33 with a total of 2,062,405 shares traded.
Over the past week, the price has changed by -8.31%, over one month by -32.58%, over three months by -17.62% and over the past year by +126.75%.
Over the past week, the price has changed by -8.31%, over one month by -32.58%, over three months by -17.62% and over the past year by +126.75%.
Is VSCO a buy, sell or hold?
Victoria's Secret has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold VSCO.
- StrongBuy: 1
- Buy: 2
- Hold: 5
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the VSCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 64.4 | 45.4% |
| Analysts Target Price | 64.4 | 45.4% |
VSCO Fundamental Data Overview March 27, 2026
P/E Trailing = 23.0881
P/E Forward = 17.0068
P/S = 0.5472
P/B = 4.2066
Revenue TTM = 6.55b USD
EBIT TTM = 46.1m USD
EBITDA TTM = 460.1m USD
Long Term Debt = 1.35b USD (from longTermDebt, two quarters ago)
Short Term Debt = 299.0m USD (from shortTermDebt, last quarter)
Debt = 2.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.33b USD (from netDebt column, last quarter)
Enterprise Value = 5.91b USD (3.59b + Debt 2.85b - CCE 518.0m)
Interest Coverage Ratio = 0.66 (Ebit TTM 46.1m / Interest Expense TTM 69.7m)
EV/FCF = 18.95x (Enterprise Value 5.91b / FCF TTM 312.0m)
FCF Yield = 5.28% (FCF TTM 312.0m / Enterprise Value 5.91b)
FCF Margin = 4.76% (FCF TTM 312.0m / Revenue TTM 6.55b)
Net Margin = 2.45% (Net Income TTM 160.9m / Revenue TTM 6.55b)
Gross Margin = 36.38% ((Revenue TTM 6.55b - Cost of Revenue TTM 4.17b) / Revenue TTM)
Gross Margin QoQ = 37.67% (prev 36.41%)
Tobins Q-Ratio = 1.18 (Enterprise Value 5.91b / Total Assets 5.01b)
Interest Expense / Debt = 0.59% (Interest Expense 16.8m / Debt 2.85b)
Taxrate = 7.42% (16.0m / 215.4m)
NOPAT = 42.7m (EBIT 46.1m * (1 - 7.42%))
Current Ratio = 1.25 (Total Current Assets 1.88b / Total Current Liabilities 1.51b)
Debt / Equity = 3.32 (Debt 2.85b / totalStockholderEquity, last quarter 856.0m)
Debt / EBITDA = 5.06 (Net Debt 2.33b / EBITDA 460.1m)
Debt / FCF = 7.46 (Net Debt 2.33b / FCF TTM 312.0m)
Total Stockholder Equity = 708.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.37% (Net Income 160.9m / Total Assets 5.01b)
RoE = 22.70% (Net Income TTM 160.9m / Total Stockholder Equity 708.5m)
RoCE = 2.24% (EBIT 46.1m / Capital Employed (Equity 708.5m + L.T.Debt 1.35b))
RoIC = 2.34% (NOPAT 42.7m / Invested Capital 1.82b)
WACC = 8.73% (E(3.59b)/V(6.43b) * Re(15.22%) + D(2.85b)/V(6.43b) * Rd(0.59%) * (1-Tc(0.07)))
Discount Rate = 15.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.25%
[DCF] Terminal Value 76.72% ; FCFF base≈286.0m ; Y1≈302.9m ; Y5≈360.3m
[DCF] Fair Price = 40.15 (EV 5.56b - Net Debt 2.33b = Equity 3.23b / Shares 80.5m; r=8.73% [WACC]; 5y FCF grow 6.48% → 3.0% )
EPS Correlation: -8.04 | EPS CAGR: 27.62% | SUE: 1.96 | # QB: 3
Revenue Correlation: 21.32 | Revenue CAGR: 12.00% | SUE: 1.36 | # QB: 6
EPS next Quarter (2026-04-30): EPS=0.32 | Chg7d=+0.000 | Chg30d=+0.232 | Revisions Net=+7 | Analysts=9
EPS current Year (2027-01-31): EPS=3.47 | Chg7d=+0.000 | Chg30d=+0.447 | Revisions Net=+10 | Growth EPS=+15.6% | Growth Revenue=+6.2%
EPS next Year (2028-01-31): EPS=4.06 | Chg7d=+0.000 | Chg30d=+0.277 | Revisions Net=+7 | Growth EPS=+17.1% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.9% (Discount Rate 15.2% - Earnings Yield 4.3%)
[Growth] Growth Spread = +2.0% (Analyst 12.9% - Implied 10.9%)
P/E Forward = 17.0068
P/S = 0.5472
P/B = 4.2066
Revenue TTM = 6.55b USD
EBIT TTM = 46.1m USD
EBITDA TTM = 460.1m USD
Long Term Debt = 1.35b USD (from longTermDebt, two quarters ago)
Short Term Debt = 299.0m USD (from shortTermDebt, last quarter)
Debt = 2.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.33b USD (from netDebt column, last quarter)
Enterprise Value = 5.91b USD (3.59b + Debt 2.85b - CCE 518.0m)
Interest Coverage Ratio = 0.66 (Ebit TTM 46.1m / Interest Expense TTM 69.7m)
EV/FCF = 18.95x (Enterprise Value 5.91b / FCF TTM 312.0m)
FCF Yield = 5.28% (FCF TTM 312.0m / Enterprise Value 5.91b)
FCF Margin = 4.76% (FCF TTM 312.0m / Revenue TTM 6.55b)
Net Margin = 2.45% (Net Income TTM 160.9m / Revenue TTM 6.55b)
Gross Margin = 36.38% ((Revenue TTM 6.55b - Cost of Revenue TTM 4.17b) / Revenue TTM)
Gross Margin QoQ = 37.67% (prev 36.41%)
Tobins Q-Ratio = 1.18 (Enterprise Value 5.91b / Total Assets 5.01b)
Interest Expense / Debt = 0.59% (Interest Expense 16.8m / Debt 2.85b)
Taxrate = 7.42% (16.0m / 215.4m)
NOPAT = 42.7m (EBIT 46.1m * (1 - 7.42%))
Current Ratio = 1.25 (Total Current Assets 1.88b / Total Current Liabilities 1.51b)
Debt / Equity = 3.32 (Debt 2.85b / totalStockholderEquity, last quarter 856.0m)
Debt / EBITDA = 5.06 (Net Debt 2.33b / EBITDA 460.1m)
Debt / FCF = 7.46 (Net Debt 2.33b / FCF TTM 312.0m)
Total Stockholder Equity = 708.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.37% (Net Income 160.9m / Total Assets 5.01b)
RoE = 22.70% (Net Income TTM 160.9m / Total Stockholder Equity 708.5m)
RoCE = 2.24% (EBIT 46.1m / Capital Employed (Equity 708.5m + L.T.Debt 1.35b))
RoIC = 2.34% (NOPAT 42.7m / Invested Capital 1.82b)
WACC = 8.73% (E(3.59b)/V(6.43b) * Re(15.22%) + D(2.85b)/V(6.43b) * Rd(0.59%) * (1-Tc(0.07)))
Discount Rate = 15.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.25%
[DCF] Terminal Value 76.72% ; FCFF base≈286.0m ; Y1≈302.9m ; Y5≈360.3m
[DCF] Fair Price = 40.15 (EV 5.56b - Net Debt 2.33b = Equity 3.23b / Shares 80.5m; r=8.73% [WACC]; 5y FCF grow 6.48% → 3.0% )
EPS Correlation: -8.04 | EPS CAGR: 27.62% | SUE: 1.96 | # QB: 3
Revenue Correlation: 21.32 | Revenue CAGR: 12.00% | SUE: 1.36 | # QB: 6
EPS next Quarter (2026-04-30): EPS=0.32 | Chg7d=+0.000 | Chg30d=+0.232 | Revisions Net=+7 | Analysts=9
EPS current Year (2027-01-31): EPS=3.47 | Chg7d=+0.000 | Chg30d=+0.447 | Revisions Net=+10 | Growth EPS=+15.6% | Growth Revenue=+6.2%
EPS next Year (2028-01-31): EPS=4.06 | Chg7d=+0.000 | Chg30d=+0.277 | Revisions Net=+7 | Growth EPS=+17.1% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.9% (Discount Rate 15.2% - Earnings Yield 4.3%)
[Growth] Growth Spread = +2.0% (Analyst 12.9% - Implied 10.9%)